Antibody-targeted superantigens in cancer immunotherapy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Immunotechnology

• Publication date

  1996-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1380-2933(96)00047-4PMID 9373308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting of superantigens

  2009cited by this paper
• Antibody‐targeted superantigen therapy induces tumor‐infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma

  1996cited by this paper
• Superantigen binding to a T cell receptor beta chain of known three- dimensional structure

  1995cited by this paper
• Crystal structure of the superantigen staphylococcal enterotoxin type A.

  1995cited by this paper
• Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.

  1995cited by this paper
• Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site.

  1995cited by this paper
• Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II

  1995cited by this paper
• Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A.

  1995cited by this paper
• Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression

  1995cited by this paper
• Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules

  1995cited by this paper
• Tumor antigens recognized by T lymphocytes.

  1994cited by this paper
• Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

  1994cited by this paper
• Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1

  1994cited by this paper
• Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.

  1994cited by this paper
• Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen

  1994cited by this paper
• Superantigen‐induced cytokines suppress growth of human colon‐carcinoma cells

  1993cited by this paper
• Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen

  1993cited by this paper
• Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.

  1993cited by this paper
• Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.

  1993cited by this paper
• Superantigens and their potential role in human disease.

  1993cited by this paper
• Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody.

  1993cited by this paper
• Superantigens: bacterial and viral proteins that manipulate the immune system.

  1993cited by this paper
• Superantigen mediated shock: a cytokine release syndrome.

  1993cited by this paper
• In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor.

  1991cited by this paper
• Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity.

  1991cited by this paper
• Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

  1991cited by this paper
• Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity.

  1991cited by this paper
• Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype.

  1991cited by this paper
• Superantigens interact with MHC class II molecules outside of the antigen groove.

  1990cited by this paper
• Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

  1990cited by this paper
• Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.

  1990cited by this paper
• High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR

  1989cited by this paper
• T‐Cell Responses to Mls and to Bacterial Proteins that Mimic its Behavior #

  1989cited by this paper
• The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

  1989cited by this paper
• The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

  1989cited by this paper
• T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells

  1988cited by this paper
• [Non-specific antitumoral activity of staphylococcal enterotoxins].

  1987cited by this paper
• Antitumor effects of immobilized protein A and staphylococcal products: linkage between toxicity and efficacy, and identification of potential tumoricidal reagents.

  1985cited by this paper
• Staphylococcal protein A (SpA) does not induce production of interferon-gamma in human mononuclear blood cells.

  1984cited by this paper
• Hudson et al.

  1977cited by this paper

• Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy

  2023cites this paper
• Gene therapy by membrane-expressed superantigen for α-fetoprotein-producing hepatocellular carcinoma

  2006cites this paper
• Superantigene modifie genetiquement pour therapie humaine

  2002cites this paper
• Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein.

  2001cites this paper
• Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma

  2000cites this paper
• Man-made superantigens: Tumor-selective agents for T-cell-based therapy.

  1998cites this paper
• Endothelial Cells Expressing an Inflammatory Phenotype Are Lysed by Superantigen-Targeted Cytotoxic T Cells

  1998cites this paper